Doxorubicinol Citrate (Mixture of Diastereomers)

 化学構造式
1242592-26-2
CAS番号.
1242592-26-2
化学名:
别名:
英語名:
Doxorubicinol Citrate (Mixture of Diastereomers)
英語别名:
Doxorubicinol Impurity 2;Doxorubicinol HCl (Mixture of Diasteromers);Doxorubicinol Citrate (Mixture of Diastereomers);Doxorubicinol-13C-d3 HCl (Mixture of Diasteromers);Doxorubicin Impurity 28( (Mixture of Diasteromers));(8S,10S)-10-[(3-AMino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-5,12-naphthacenedione Citrate
CBNumber:
CB72509168
化学式:
C33H39NO18
分子量:
737.65866
MOL File:
1242592-26-2.mol

Doxorubicinol Citrate (Mixture of Diastereomers) 物理性質

融点 :
195-201?C
貯蔵温度 :
-20°C Freezer

安全性情報

Doxorubicinol Citrate (Mixture of Diastereomers) 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

Doxorubicinol Citrate (Mixture of Diastereomers) 化学特性,用途語,生産方法

化学的特性

Dark Red Solid

使用

A metabolite of Doxorubicin as neoplasm inhibitor

Doxorubicinol Citrate (Mixture of Diastereomers) 上流と下流の製品情報

原材料

準備製品


Doxorubicinol Citrate (Mixture of Diastereomers) 生産企業

Global( 7)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Chemsky (shanghai) International Co.,Ltd 021-50135380
shchemsky@sina.com China 15421 60
QUALITY CONTROL SOLUTIONS LTD. 13670046396
ORDERS@QCSRM.COM China 18820 58
United States Biological --
sales@advtechind.com United States 6106 58

1242592-26-2()キーワード:


  • 1242592-26-2
  • Doxorubicinol Citrate (Mixture of Diastereomers)
  • (8S,10S)-10-[(3-AMino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-5,12-naphthacenedione Citrate
  • Doxorubicinol HCl (Mixture of Diasteromers)
  • Doxorubicinol-13C-d3 HCl (Mixture of Diasteromers)
  • Doxorubicin Impurity 28( (Mixture of Diasteromers))
  • Doxorubicinol Impurity 2
Copyright 2017 © ChemicalBook. All rights reserved